ES542613A0 - Un procedimiento para la preparacion de compuesto denominado cl-1724b-2 - Google Patents

Un procedimiento para la preparacion de compuesto denominado cl-1724b-2

Info

Publication number
ES542613A0
ES542613A0 ES542613A ES542613A ES542613A0 ES 542613 A0 ES542613 A0 ES 542613A0 ES 542613 A ES542613 A ES 542613A ES 542613 A ES542613 A ES 542613A ES 542613 A0 ES542613 A0 ES 542613A0
Authority
ES
Spain
Prior art keywords
procedure
preparation
compound called
compound
called
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES542613A
Other languages
English (en)
Other versions
ES8700316A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Warner Lambert Co LLC
Original Assignee
Warner Lambert Co LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co LLC filed Critical Warner Lambert Co LLC
Publication of ES542613A0 publication Critical patent/ES542613A0/es
Publication of ES8700316A1 publication Critical patent/ES8700316A1/es
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H11/00Compounds containing saccharide radicals esterified by inorganic acids; Metal salts thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20Bacteria; Culture media therefor
    • C12N1/205Bacterial isolates
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P1/00Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes
    • C12P1/06Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes by using actinomycetales
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12RINDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00Microorganisms ; Processes using microorganisms
    • C12R2001/01Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/04Actinomyces

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Mycology (AREA)
  • Biomedical Technology (AREA)
  • Virology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
ES542613A 1984-05-04 1985-04-26 Un procedimiento para la preparacion de compuesto denominado cl-1724b-2 Expired ES8700316A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/607,056 US4554162A (en) 1984-05-04 1984-05-04 CL-1724 Antibiotic compounds, their production and use

Publications (2)

Publication Number Publication Date
ES542613A0 true ES542613A0 (es) 1986-10-01
ES8700316A1 ES8700316A1 (es) 1986-10-01

Family

ID=24430626

Family Applications (1)

Application Number Title Priority Date Filing Date
ES542613A Expired ES8700316A1 (es) 1984-05-04 1985-04-26 Un procedimiento para la preparacion de compuesto denominado cl-1724b-2

Country Status (8)

Country Link
US (1) US4554162A (es)
EP (1) EP0161849A3 (es)
JP (1) JPS60259191A (es)
AU (1) AU581886B2 (es)
CA (1) CA1232853A (es)
DK (1) DK166485A (es)
ES (1) ES8700316A1 (es)
ZA (1) ZA852775B (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5037651A (en) * 1987-01-30 1991-08-06 American Cyanamid Company Dihydro derivatives of LL-E33288 antibiotics
US4939244A (en) * 1987-01-30 1990-07-03 American Cyanamid Company Pseudoaglycones of LL-E33288 antibiotics
JP2646707B2 (ja) * 1987-10-26 1997-08-27 藤沢薬品工業株式会社 新規化合物wf2015aおよびb、それらの製造法ならびにそれらを含有する組成物
US5606040A (en) * 1987-10-30 1997-02-25 American Cyanamid Company Antitumor and antibacterial substituted disulfide derivatives prepared from compounds possessing a methyl-trithio group
US4996305A (en) * 1988-02-29 1991-02-26 American Cyanamid Company Process for producing the antibiotic and antitumor agents LL-E33288.epsilon.ε-Br
US20040023910A1 (en) * 2001-09-28 2004-02-05 Zhiming Zhang Use of cyr61 in the treatment and diagnosis of human uterine leiomyomas
AR048098A1 (es) * 2004-03-15 2006-03-29 Wyeth Corp Conjugados de caliqueamicina
BRPI0619476A2 (pt) * 2005-12-05 2011-10-04 Wyeth Corp composições de interleucina-11 e métodos de uso
US9493562B2 (en) 2012-07-19 2016-11-15 Alethia Biotherapeutics Inc. Anti-Siglec-15 antibodies

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4578271A (en) * 1982-05-24 1986-03-25 Fujisawa Pharmaceutical Co., Ltd. Biologically active WS 6049 substances, a process for the production thereof and their pharmaceutical compositions
US4539203A (en) * 1984-11-13 1985-09-03 Warner-Lambert Company CL-1577D And CL-1577E antibiotic/antitumor compounds, their production and use

Also Published As

Publication number Publication date
DK166485A (da) 1985-11-05
DK166485D0 (da) 1985-04-12
ZA852775B (en) 1985-11-27
EP0161849A3 (en) 1987-05-13
JPS60259191A (ja) 1985-12-21
ES8700316A1 (es) 1986-10-01
AU581886B2 (en) 1989-03-09
US4554162A (en) 1985-11-19
EP0161849A2 (en) 1985-11-21
AU4123585A (en) 1985-11-07
CA1232853A (en) 1988-02-16

Similar Documents

Publication Publication Date Title
ES540366A0 (es) Un procedimiento para la preparacion de un compuesto
ES547840A0 (es) Un procedimiento para la preparacion de alquilsulfonamidofe-nilalquilaminas
ES557126A0 (es) Un procedimiento para la preparacion de triazolobenzodiazepinas
ES541386A0 (es) Un procedimiento para la preparacion de un compuesto
ES551552A0 (es) Un procedimiento para la preparacion de nuevos compuestos de sulfonilurea
ES540200A0 (es) Un procedimiento para la preparacion de acidos 7-amino-3-me-til sustituido-3-defem-4-carboxilicos
ES544970A0 (es) Un procedimiento para la preparacion de derivados de benzo- tiofeno
ES552402A0 (es) Un procedimiento para la preparacion de 4-amino-2-fenil-quinolinas
ES553602A0 (es) Un procedimiento para la preparacion de nuevas quinazolindionas
ES542613A0 (es) Un procedimiento para la preparacion de compuesto denominado cl-1724b-2
ES541373A0 (es) Un procedimiento para la preparacion de un compuesto de 2-oxindol-1-carboxamida
ES548960A0 (es) Un procedimiento para la preparacion de derivados de hidan- toina
ES551508A0 (es) Un procedimiento para la preparacion de nuevas sulfonilureas
ES535494A0 (es) Un procedimiento para la preparacion de un compuesto de b-lactama
ES557267A0 (es) Un procedimiento para la preparacion de derivados amidinofenilicos
ES542517A0 (es) Un procedimiento para la preparacion de monoalquil-polial- quilenpoliaminas
ES531528A0 (es) Un procedimiento para la preparacion de un compuesto
ES544397A0 (es) Un procedimiento para la preparacion de un compuesto
ES542674A0 (es) Un procedimiento para la preparacion de compuestos de cefa- losporina
ES552988A0 (es) Un procedimiento para la preparacion de piridazinilimidazolidinonas
ES547054A0 (es) Un procedimiento para la preparacion de un compuesto de 1,3 -diacil-2-oxindol
ES551129A0 (es) Un procedimiento para la preparacion de nuevas 3-alcoxi-2-(n-pirrolidino)-n-pirimidinil- o n-pirazinil-propilaminas
ES544214A0 (es) Un procedimiento para la preparacion de un derivado de n-metil-1-alquiltio-2-nitroetonamina
ES553605A0 (es) Un procedimiento para la preparacion de derivados de carbpenem
ES551275A0 (es) Un procedimiento para la preparacion de un compuesto de 2-oxindol-1-carboxamida